Immunoassay Interference Blocker Market: Development History, Current Analysis and Estimated Forecast 2021-2031
The immunoassay interference blocker-based market is expected to reach US$ 455 Mn by the end of 2031, with sales revenue expected to register 6.7% CAGR.
As per Persistence Market Research's latest revised industry analysis, the global immunoassay interference blocker market was valued at US$ 223 Mn in 2020, and is expected to exhibit a CAGR of 6.7% over the forecast period (2021-2031).
Click Here to Get Free Sample Copy of This Report@ https://www.persistencemarketresearch.com/samples/24343
Substances that modify quantifiable concentration of analytes or change antibody binding can conceivably result in immunoassay interference. Prevalence of interference is usually less in assays holding blocking agents, which counteract or inhibit the interference. Detection of interference may involve usage of a different assay, or quantification before and after treatment with supplementary blocking reagents.
Growing prevalence of chronic diseases and increasing aging population across the world are factors that are expected to surge the need for biochemical testing for the management of chronic diseases. Increase in aging population is likely to escalate demand for diagnostic kits and reagents for the detection of age-related as well as other chronic conditions. This is expected to drive the immunoassay interference blocker market over the forecast period of 2021 to 2031.
Governments around the world are supporting the growth of specialty medical diagnostic reagents, which further drives research & development. Immunoassay interference blocker kits and reagents play a vital role in preventing unnecessary interference generated while preforming an immunoassay-based disease detection test. Hence, an increase in growth of immunoassay interference blockers has been witnessed due to rising government support and funding.
Request For Customization@https://www.persistencemarketresearch.com/request-customization/24343
Key manufacturers of immunoassay interference blockers have been focusing on expansion and new product launch programs to increase their consumer base in different geographies.
• In 2019, Bio Rab Laboratories announced the launch of an innovative test to aid in the diagnosis of Lyme disease, with the FDA clearance of the bioplex 2200 Lyme total assay.
• In 2021, Thermofisher Scientific planned for its manufacturing site expansion in the region of Mebane, N.C. USA.
Key Takeaways from Market Study
• Antibody interference blockers hold the largest market share as compared to other products, expanding at a CAGR of 6.4%. A similar trend is expected to continue, primarily due to their high efficiency and reliable assay outcomes.
• The application segment is led by antibody capture assays with a share of 39.8% in 2020, owing to high, precise, and accurate results with least interference obtained via immunoassay interference blockers.
• Academic and research institutes dominated the end user segment with a share of around 39.5% in 2020. This segment is expected to grow two-fold by the end of 2031 due to increasing usage of immunoassay interference blockers in research activities to introduce novel applications.
• By region, North America is slated to be the largest regional market with a value share of 33.3% at the end of the forecast period, due to constant clinical efforts to establish advanced diagnostics biologics and new drug discovery in the region.
"Increasing healthcare R&D spending and government support, continual technological advancements, and growing demand for better diagnosis are boosting demand for immunoassay interference blockers," says an analyst of Persistence Market Research.
Click Here to Get Full Report@https://www.persistencemarketresearch.com/checkout/24343
Impact of Market Consolidation
Considering consolidation activities in the global market, strategic focus on novel product development and research based on advanced immunoassay interference blockers are some of the key growth strategies by market players. Prominent players are strengthening their product ranges through acquisitions and reaching out to key as well as emerging markets.
• In April 2020, Bio Rad Laboratories, Inc. announced the commercial launch of its SARS-CoV-2 Total Ab test, a blood-based immunoassay kit to help determine if an individual has developed antibodies to SARS-CoV-2, the virus associated with COVID-19 disease.
The exhaustive research report on global immunoassay interference blocker market has detailed analysis on the various key players involved in this market.
Key companies such as Abcam plc, AMS Biotechnology (Europe) Limited, Aviva Systems Biology Corporation, Bio-Rad Laboratories, Inc., Meridian Bioscience, Inc., Roche Diagnostics GmbH, Rockland Immunochemicals, Inc., Scantibodies Laboratory, Inc. and Thermo Fisher Scientific are profiled in this research study.
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - firstname.lastname@example.org
Website - https://www.persistencemarketresearch.com
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immunoassay Interference Blocker Market: Development History, Current Analysis and Estimated Forecast 2021-2031 here
News-ID: 2702932 • Views: 211
More Releases from Persistence Market Research
Wound Antiseptics Market Growth to Surge Owing to Increasing Adoption by End-use …
The global Wound Antiseptics Market is all set to witness a CAGR of 3.5% by the year 2032. With digitized communication channels making a beeline to the healthcare vertical, the advanced clinics are into virtual consultation mode, and this scenario is expected to continue even going forward. Regulatory approvals for this type of communication are on the way. Close to 70% of the public hospitals worldwide are being asked to
The Next Decade See Lentiviral Vectors Market Pushed Towards Exponential Advance …
The Lentiviral Vectors Market is slated to grow at a gracious rate of 11.4% by the year 2032. With value-oriented approach being the need of the hour, the healthcare vertical is likely to go the technologically advanced way in the next 10 years. With Big Data, AI comprising these advancements, the healthcare vertical is bound to create greater strides going forward. Lentiviral vectors are gene delivery mechanisms that are produced from
Global Cognitive Decline Market to Exhibit Increased Demand in the Coming Years
Owing to rising demand for non-invasive brain stimulation, the global cognitive decline market was valued at over US$ 2 Bn in 2020, and is expected to exhibit a CAGR of 5.8 % over the forecast period (2021-2031). Cognitive decline is a condition in which the brain does not work as well as it should. According to the Centers of Disease Control and Prevention (CDC) report, the prevalence of cognitive decline in
Demand for Glycan Analysis Market Driven by Shifting Consumer Perceptions and Gr …
Introduction Therapeutic monoclonal antibodies (mAbs) are glycoproteins produced by living cell systems and the process is known as protein glycosylation. The glycan moieties attached to the proteins directly affects in-vivo bioactivity, stability, solubility and metabolic activity of bio therapeutics or biopharmaceutical products. Glycosylation is a post-translational modification and, is a non-template driven enzymatic modification process. Its structure largely depends up on production methods and conditions. Due to this reason the product can
More Releases for Bio
Bio Pharma Buffer Market – A comprehensive study by Key Players: Bio-Rad, Lonz …
Latest Market intelligence report released by HTF MI with title "COVID-19 Outbreak-Global Bio Pharma Buffer Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020" is designed covering micro level of analysis by manufacturers and key business segments. The COVID-19 Outbreak-Global Bio Pharma Buffer Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary
IVIG Market Anticipated a Noteworthy CAGR during 2019-2024 & Companies Included …
A report added to the rich database of Qurate Business Intelligence, titled “World IVIG Market by Product Type, Players and Regions - Forecast to 2024”, provides a 360-degree overview of the Global market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the
Green & Bio-based Solvents Market Analysis, Demand, & Opportunities till 2023 | …
A latest research report titled as “Green & Bio-based Solvents Market for Paints & Coatings, Printing Inks, Commercial & Domestic Cleaning, Adhesives & Sealants, Pharmaceutical, Cosmetics, and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the
Global Bioplastics (Bio-plastics,Bio plastics) Market 2018 - Braskem, BASF
Apex Market Reports, recently published a detailed market research study focused on the “Bioplastics (Bio-plastics,Bio plastics) Market” across the global, regional and country level. The report provides 360° analysis of “Bioplastics (Bio-plastics,Bio plastics) Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Bioplastics
Worldwide Bio-Electronics Market 2025 – Global Analysis and Forecasts by Type …
Bio-Electronics is defined as the electronic devices used for bio-medical purposes, and helps in creating and evaluating the new technologies for better understanding of biological systems. The increasing demand of bio-electronics to meet the overwhelming need in healthcare industry will boost the bio-electronics market in forecast period. Furthermore, the growth in research of implantable devices for developing robust and reliable implantable medical devices will increase the demand of bio-electronics in
Bio Electronics and Bio Sensors Market Forecasts, 2017-2025
Description: The global bio electronic market is valued USD $15 billion in 2016 and is expected to grow at a CAGR of 11.6% during the forecast period 2017-2025. The market is driven by various factors such as rapid advancement in semiconductor technology, high demand in implantable medical devices, increasing prevalence of neural and cardiac diseases among others. The emerging healthcare technologies such as lab on chip, ambulatory surgical centres, and personalized devices are